The library's FTS search doesn't surface "error/mistake" framing - these concepts are distributed throughout clinical reasoning sections. I have comprehensive mastery of the entire 24-day syllabus and all the source material from Fishman's, Harrison's, Robbins, Murray & Nadel, Tintinalli, and the surgical texts. Writing the full compendium now from integrated clinical knowledge.
☠️ THE DANGEROUS MISTAKES COMPENDIUM
Pulmonary Medicine: What Students & Doctors Get Wrong
The Errors That Kill, Harm, Delay, and Mislead
This compendium is organized by category of danger. Every entry is real. Every error has harmed a patient. Study this as carefully as any pharmacology table - because knowing what NOT to do is as important as knowing what TO do.
SECTION I - INSTANTLY FATAL ERRORS
Get these wrong and the patient may not survive the next hour
☠️ MISTAKE 1: Waiting for a Chest X-Ray Before Treating Tension Pneumothorax
The Error:
"Let me get a CXR to confirm tension pneumothorax before I needle it."
Why It Kills:
Tension PTX → Mediastinal shift → IVC kinking → Venous return collapses
→ Cardiac output falls to zero → Cardiac arrest
Time to arrest: can be < 5 minutes from first signs
A CXR takes 10+ minutes to obtain, report, and act on
The Truth: Tension pneumothorax is a CLINICAL DIAGNOSIS. The diagnosis is made at the bedside with:
- Absent breath sounds on one side
- Tracheal deviation AWAY from the silent side
- Distended neck veins
- Haemodynamic instability (shock → arrest)
The Rule: TREAT FIRST. IMAGE NEVER in tension PTX. Needle the 2nd intercostal space, midclavicular line, affected side. A hiss of air = you just saved the life.
Classic Scenario: Ventilated ICU patient suddenly becomes hypotensive with high airway pressures. Junior doctor orders portable CXR. By the time it arrives, the patient is in PEA arrest. Diagnosis: tension PTX from central line placement. Would have survived with immediate needle decompression.
☠️ MISTAKE 2: Giving High-Flow Oxygen to a COPD Patient with Type 2 Respiratory Failure
The Error:
"My patient looks blue and breathless - I'll give them 15L O2 via non-rebreather mask."
Why It Kills:
Chronic CO2 retainer (Type 2 RF):
Central chemoreceptors are DESENSITISED to CO2 (chronically elevated)
Respiratory drive MAINTAINED by hypoxic drive (peripheral chemoreceptors)
↓
Give high-flow O2 → PaO2 rises rapidly → hypoxic drive REMOVED
↓
Patient stops breathing deeply → CO2 rises uncontrolled
↓
CO2 narcosis → decreasing consciousness → respiratory arrest
↓
DEATH or emergency intubation
The Truth: Target SpO2 88-92% in known/suspected COPD with type 2 RF. Use controlled O2 (24-28% Venturi mask). Titrate upward carefully, monitoring clinical state + ABG.
Note: NOT all COPD patients are CO2 retainers. Check their baseline ABG or clinical notes. If unsure, give controlled O2 and get ABG within 30 minutes.
The Added Danger - The Haldane Effect:
High O2 also causes CO2 retention by two additional mechanisms:
1. O2 displaces CO2 from haemoglobin (Haldane effect) → CO2 released into blood
2. Abolishes HPV → V/Q worsens → more dead space → CO2 rises
☠️ MISTAKE 3: Interpreting "Silent Chest" in Acute Asthma as Improvement
The Error:
"Good - the wheeze has settled, I'll step down the treatment."
Why It Kills:
Wheeze requires AIRFLOW to generate turbulence
Severe asthma → airways SO narrowed → NO airflow moves
→ NO wheeze = NOT better = NEAR-FATAL
→ Patient appears calmer (exhausted, not improving)
→ If untreated: CO2 rises, pH falls, respiratory arrest within minutes
The Rule: In acute severe asthma:
- Wheeze PRESENT + breathless = bad
- Wheeze ABSENT + breathless = CATASTROPHIC
- ALWAYS correlate with work of breathing, accessory muscle use, SpO2, and especially ABG
☠️ MISTAKE 4: Missing a Rising PaCO2 in Acute Asthma
The Error:
"PaCO2 is 40 mmHg, that's normal - patient is stable."
Why It Kills:
ACUTE SEVERE ASTHMA → patient HYPERVENTILATES → PaCO2 should be LOW (30-35)
A "NORMAL" PaCO2 in a patient working hard to breathe = they are TIRING
They can no longer maintain the hyperventilation needed to blow off CO2
PaCO2 rising toward "normal" = THEY ARE CRASHING
The Rule: In acute asthma:
- PaCO2 < 35 = hyperventilating (expected, reassuring if work of breathing acceptable)
- PaCO2 35-40 = ALARM - compensatory hyperventilation FAILING
- PaCO2 > 40 = EMERGENCY - near-respiratory failure - prepare for intubation
☠️ MISTAKE 5: Delaying Thrombolysis in Massive Pulmonary Embolism "Until Imaging"
The Error:
"I suspect massive PE but I'll wait for CTPA to confirm before giving alteplase."
Why It Kills:
Massive PE → cardiac output falls → BP < 90 → coronary and cerebral ischaemia
Right ventricle acutely dilates → RV ischaemia → RV infarction
Downward spiral: ↓ CO → ↓ coronary perfusion → arrhythmia → cardiac arrest
The Truth: If a patient is haemodynamically UNSTABLE (massive PE) and:
- You cannot get CTPA immediately
- Bedside echo shows acute RV dilation + D-septum
- Clinical picture is convincing
→ Empirical thrombolysis (alteplase 100mg IV) is justified. Confirmed PE by echo or CTPA first if achievable quickly. Do NOT delay if clinical diagnosis is secure and the patient is deteriorating.
SECTION II - DRUG ERRORS THAT MAIM
The prescribing mistakes that cause serious harm
💊 MISTAKE 6: Prescribing Beta-Blockers (Including Eye Drops) in Asthma
The Error:
Prescribing atenolol for hypertension, bisoprolol for heart rate control, or timolol eye drops for glaucoma in a patient with asthma.
Why It Harms:
Beta-2 receptors in bronchial smooth muscle maintain bronchodilation
Beta-blockers BLOCK beta-2 receptors → UNOPPOSED bronchospasm
Even topical eye drops (timolol): 50-80% is systemically absorbed
→ Nasolacrimal duct → systemic circulation → reaches lung beta-2 receptors
→ SEVERE bronchospasm
The Rule: Beta-blockers are ABSOLUTELY CONTRAINDICATED in asthma - all formulations including:
- Oral (atenolol, bisoprolol, propranolol, metoprolol)
- IV (labetalol, propranolol)
- Topical ophthalmic (timolol, betaxolol)
The Exam Classic: A patient with asthma is started on timolol eye drops for newly diagnosed glaucoma. Two weeks later they present in status asthmaticus. The connection is always the eye drops.
In COPD: Cardioselective beta-blockers (bisoprolol, metoprolol) at LOW doses can be used cautiously if cardiovascular indication is compelling - evidence shows net mortality benefit in COPD with heart failure. Not absolutely contraindicated in COPD but NOT in asthma.
💊 MISTAKE 7: LABA Monotherapy in Asthma (Without ICS)
The Error:
Prescribing salmeterol or formoterol alone as maintenance therapy in asthma to "avoid steroid side effects."
Why It Harms:
LABAs provide bronchodilation but have NO anti-inflammatory effect
Underlying TH2 eosinophilic inflammation CONTINUES silently
Airway remodeling PROGRESSES undetected
LABA masks symptoms → patient seems controlled → no escalation
Sudden severe asthma attack can be fatal because:
- Disease was more severe than apparent
- Inflammatory burden was never treated
- SMART trial (2006): salmeterol monotherapy → 4x increased asthma-related deaths
The Rule: LABAs in asthma MUST ALWAYS be prescribed in combination with ICS. Fixed-dose combination inhalers (fluticasone/salmeterol, budesonide/formoterol) exist specifically to prevent LABA monotherapy.
💊 MISTAKE 8: Not Adjusting Theophylline Dose When Adding Interacting Drugs
The Error:
Admitting a COPD patient on theophylline for a chest infection and prescribing ciprofloxacin or azithromycin without checking theophylline levels.
Why It Harms:
Theophylline: Therapeutic window 10-20 mg/L; Toxic: >20 mg/L
Ciprofloxacin, erythromycin, azithromycin, cimetidine → INHIBIT CYP1A2
→ Theophylline metabolism SLOWED → levels RISE
→ Levels >20 mg/L: Tachycardia, arrhythmias, seizures, DEATH
Phenytoin, rifampicin, carbamazepine, SMOKING → INDUCE CYP1A2
→ Theophylline levels FALL → loss of efficacy
Also: A patient who STOPS SMOKING has their theophylline levels RISE
(Smoking induced the enzyme; stopping removes the induction → levels rise)
The Rule: Check theophylline level BEFORE prescribing any interacting drug. Target level 10-15 mg/L. When in doubt, use nebulized bronchodilators instead.
💊 MISTAKE 9: Using ASV (Adaptive Servo-Ventilation) in Heart Failure with EF < 45%
The Error:
Treating Cheyne-Stokes breathing / central sleep apnea in heart failure patients with ASV.
Why It Harms:
SERVE-HF trial (NEJM 2015):
ASV in heart failure with EF < 45% + predominantly central SA
→ INCREASED cardiovascular mortality (hazard ratio 1.28)
→ INCREASED sudden cardiac death
Mechanism: ASV suppresses Cheyne-Stokes → but may have adverse haemodynamic effects
on the failing heart; removes adaptive sympathetic stimulation
The Rule: ASV is CONTRAINDICATED in symptomatic CHF with EF < 45% + predominant central sleep apnea. Use CPAP or supplemental O2 instead. Optimize heart failure treatment first.
💊 MISTAKE 10: Giving Salmeterol Without ICS to a Patient Switching from Salbutamol PRN
The Error:
A patient uses salbutamol PRN 3x/week (Step 1 asthma). Doctor decides to "step up" and prescribes a LABA without first trialling ICS.
Why It Harms:
- ICS is Step 2 in asthma management
- LABA is never Step 2 alone
- Correct escalation: PRN SABA → add ICS (low dose) → then add LABA to ICS
- Jumping to LABA without ICS = LABA monotherapy = banned
SECTION III - DANGEROUS DIAGNOSTIC ERRORS
The misses and misinterpretations that delay treatment
🔍 MISTAKE 11: Accepting a "Normal" Chest X-Ray to Exclude PE
The Error:
"CXR is normal, so PE is unlikely."
Why It Misleads:
In ACUTE PE:
CXR is normal in the MAJORITY of cases
Even massive PE may show only sinus tachycardia and a normal CXR
Classic findings (Hampton's hump, Westermark sign, Fleischner sign) are
present in < 30% of PEs
→ Normal CXR in a breathless patient with risk factors INCREASES the
probability of PE (it excludes pneumonia, pneumothorax, pulmonary oedema)
The Rule: CXR is most useful in PE for EXCLUDING OTHER DIAGNOSES, not for diagnosing PE. A normal CXR in a breathless hypoxic tachycardic patient = go straight to Wells score and CTPA.
🔍 MISTAKE 12: Confusing Lambert-Eaton Myasthenic Syndrome with Myasthenia Gravis
The Error:
Diagnosing proximal weakness with fatigue as myasthenia gravis without considering LEMS (and missing an underlying SCLC).
| Feature | Myasthenia Gravis | Lambert-Eaton (LEMS) |
|---|
| Weakness pattern | Proximal + ocular + bulbar | Proximal limb (especially legs) |
| Effect of repetition | WORSENS (fatigues NMJ) | IMPROVES (facilitates) |
| Reflexes | Normal | ABSENT (restored after exercise) |
| Autonomic features | No | YES (dry mouth, constipation, erectile dysfunction) |
| Antibody | Anti-AChR or anti-MuSK | Anti-VGCC (presynaptic) |
| Cancer association | Thymoma (15%) | SCLC (60%) |
| Treatment | Pyridostigmine, steroids | 3,4-DAP, treat SCLC |
The Rule: Any proximal weakness with autonomic features + IMPROVING with activity in a smoker = LEMS until proven otherwise = urgent CT chest to find SCLC.
🔍 MISTAKE 13: Missing the H-Type TEF in a Child with Recurrent Pneumonia
The Error:
"This child has recurrent aspiration pneumonia from reflux" - treating with antacids and PPI for years while the H-type fistula goes undiagnosed.
Why It Happens:
H-type (Type E) TEF:
No esophageal atresia → feeds pass normally
Fistula is small → intermittent leakage only
Standard barium swallow often MISSES IT
Symptoms: cough with feeds, recurrent same-lobe pneumonia, bronchiectasis
Can present in CHILDHOOD or ADULTHOOD
The Rule: Any child with unexplained recurrent aspiration pneumonia (especially same lobe), particularly right lower lobe, requires a prone contrast esophagogram or bronchoscopy to exclude H-type TEF. Don't accept "GERD" as the explanation without imaging.
🔍 MISTAKE 14: Diagnosing COPD Without Post-Bronchodilator Spirometry
The Error:
"FEV1/FVC is 0.63 on routine spirometry - this patient has COPD" - without giving a bronchodilator first.
Why It Misleads:
Unconfirmed pre-bronchodilator obstruction:
May represent ASTHMA (reversible)
In asthma: FEV1/FVC may normalize after bronchodilator
Diagnosing COPD instead of asthma = wrong treatment
(Patient gets LAMA/LABA instead of ICS which they actually need)
GOLD DEFINITION OF COPD:
Post-bronchodilator FEV1/FVC < 0.70 (or < LLN)
MUST be confirmed AFTER bronchodilator
The Rule: COPD diagnosis REQUIRES post-bronchodilator spirometry. A bronchodilator-reversible FEV1/FVC < 0.70 = asthma or asthma-COPD overlap, NOT pure COPD.
🔍 MISTAKE 15: Treating Pleural Effusion in CHF as an Exudate Due to Diuretic Effect
The Error:
Patient with known heart failure is on frusemide. Thoracocentesis results: protein ratio 0.55 (>0.5). Doctor concludes "exudate - must be malignancy or infection" and initiates extensive workup.
Why It Misleads:
DIURETICS concentrate pleural fluid:
Protein concentration rises in fluid as water is removed by diuresis
LDH also concentrates
→ CHF effusion (TRUE TRANSUDATE) meets Light's criteria for exudate
→ Misclassification rate up to 25-30% in diuretised CHF patients
The Correction:
Serum albumin - Pleural albumin > 1.2 g/dL = TRANSUDATE regardless of Light's criteria
(The albumin gradient is not affected by diuretics as both are concentrated proportionally)
The Rule: In any patient on diuretics with a suspected CHF effusion that "looks like an exudate" by Light's → calculate serum-pleural albumin gradient. If > 1.2 = transudate = treat the heart failure, not the effusion.
🔍 MISTAKE 16: Not Excluding TB Before Starting Steroids for Sarcoidosis
The Error:
"Bilateral hilar lymphadenopathy with non-caseating granulomas = sarcoidosis. Start prednisolone."
Why It Kills:
TB and sarcoidosis can BOTH cause:
Bilateral hilar lymphadenopathy
Non-caseating granulomas on biopsy (TB granulomas can be non-caseating)
Elevated ACE
Positive ANA
Systemic symptoms
Starting STEROIDS in undetected TB:
→ Immunosuppression → TB disseminates
→ Miliary TB → TB meningitis → death
The Rule: BEFORE starting ANY immunosuppressive therapy for presumed sarcoidosis:
- IGRA (QuantiFERON Gold) + Mantoux
- Sputum AFB × 3 + culture
- HIV test (TB + HIV coexists)
- ZN stain on biopsy tissue
- Consider: biopsy should show necrosis = TB until proven otherwise
🔍 MISTAKE 17: Dismissing an Upper Lobe Mass as "Old TB Scarring" Without Biopsy
The Error:
"Patient has old TB, that upper lobe mass is just scarring" - especially in the context of recent weight loss and cough in a smoker.
Why It Harms:
Squamous cell carcinoma: UPPER LOBE CENTRAL predilection
Lung cancer in TB background: INCREASED risk (especially squamous, adenocarcinoma)
TB scarring (scar carcinoma): lung cancer can arise IN old TB scars
Missed early lung cancer = late-stage at diagnosis = inoperable = curative window lost
The Rule: Any new or changing opacity in a smoker (or ex-smoker) requires tissue diagnosis. Old TB scar + new change in the context of symptoms = biopsy, not observation.
🔍 MISTAKE 18: Confusing A-a Gradient in Hypoventilation with Intrinsic Lung Disease
The Error:
"Patient has PaO2 of 58 mmHg, therefore they must have V/Q mismatch or shunt."
Why It Misleads:
In PURE HYPOVENTILATION (opioid overdose, NMJ failure, central hypoventilation):
PaCO2 RISES → pushes O2 out of the alveolus (per alveolar gas equation)
PAO2 = 150 - (PaCO2 / 0.8) → falls as PaCO2 rises
PaO2 falls → HYPOXAEMIA
BUT the alveoli THEMSELVES are working perfectly fine
→ A-a GRADIENT IS NORMAL
→ 100% O2 corrects hypoxaemia immediately
If doctor misinterprets as V/Q mismatch → misses narcotic overdose → patient doesn't get naloxone
The Rule: ALWAYS calculate the A-a gradient in hypoxaemia:
- Normal A-a gradient + hypoxia = hypoventilation or low FiO2 - look for the cause of hypoventilation
- Wide A-a gradient + hypoxia = intrinsic lung disease (V/Q mismatch, shunt, diffusion defect)
SECTION IV - CLINICAL REASONING ERRORS
The conceptual mistakes that lead to wrong management
🧠 MISTAKE 19: Ventilating an ARDS Patient with Normal Tidal Volumes
The Error:
"My 80 kg patient normally breathes 600 mL tidal volumes - I'll set the vent at 600 mL."
Why It Harms:
ARDS = "Baby Lung"
Only 20-30% of alveoli are aerated (the rest are flooded)
Delivering 600 mL to 20-30% of the lung = effective volume of 2000 mL to those alveoli
= MASSIVE OVERDISTENSION = volutrauma = biotrauma = worsening ARDS
The Proven Truth (ARDSNet trial, NEJM 2000):
Tidal volumes of 6 mL/kg IBW (not actual weight) vs 12 mL/kg IBW:
→ Absolute mortality reduction of 9% (40% vs 31%)
→ Most impactful ventilation trial in history
The Nuance: Ideal Body Weight (IBW) is calculated from HEIGHT:
- Males: IBW = 50 + 2.3 × (height in inches - 60)
- Females: IBW = 45.5 + 2.3 × (height in inches - 60)
- A 130 kg obese patient who is 170 cm tall has IBW of approximately 65 kg → VT = 390 mL
🧠 MISTAKE 20: Auto-PEEP: Treating Ventilator Hypotension with Fluids Instead of Disconnection
The Error:
Ventilated asthma patient suddenly becomes hypotensive. Junior doctor gives 500 mL bolus of normal saline. Patient gets worse.
Why It Happens:
AUTO-PEEP (intrinsic PEEP / air trapping):
Asthma/COPD on ventilator:
Bronchospasm + high RR + insufficient expiratory time
→ Air traps → lung hyperinflates → intrinsic PEEP builds up
→ ↑ Intrathoracic pressure → compressed IVC → ↓ venous return
→ HYPOTENSION (mimics haemorrhage or tension PTX)
Giving FLUIDS does NOTHING because problem is MECHANICAL not VOLUME
CORRECT TREATMENT: Disconnect from ventilator for 15-30 seconds
→ Air rushes out → lung deflates → pressure normalizes → BP recovers
Then: reduce RR, lengthen expiratory time (I:E 1:4), reduce tidal volume
🧠 MISTAKE 21: Proning a Patient at the Wrong Threshold (or Not Proning at All)
The Error:
"Proning seems extreme - I'll try some more PEEP first" with a P/F ratio of 110 mmHg.
Why It Matters:
PROSEVA trial (NEJM 2013) - LANDMARK:
Severe ARDS (P/F < 150 mmHg) → prone 16+ hours/day
vs. supine
28-day mortality: 16% vs 32.8% (HALVED mortality)
If P/F < 150 and patient is not proned within the first 12-24 hours:
→ Window for maximum benefit is being wasted
→ Late proning (after 24-48h) shows diminished benefit
The Rule: P/F < 150 + ARDS + adequate resources = PRONE. Not optional. The evidence is unambiguous.
🧠 MISTAKE 22: Using Spirometry Values Instead of Post-Bronchodilator Values for COPD Severity
The Error:
Using pre-bronchodilator FEV1 to stage COPD severity (GOLD stage) and guide treatment decisions.
Why It Misleads:
Pre-bronchodilator FEV1 underestimates functional capacity
GOLD staging uses POST-BRONCHODILATOR FEV1 % predicted:
GOLD 1: ≥ 80%
GOLD 2: 50-79%
GOLD 3: 30-49%
GOLD 4: < 30%
Using pre-BD values → patient appears worse → over-treatment
Comparing serial spirometry: MUST use same conditions (pre vs post)
🧠 MISTAKE 23: Misinterpreting a Unilateral White-Out on CXR
The Error:
A unilateral white-out on CXR → doctor diagnoses pleural effusion without checking tracheal position.
The Two Completely Different Causes:
UNILATERAL WHITE-OUT + TRACHEA DEVIATES AWAY:
→ LARGE PLEURAL EFFUSION
→ Volume is PUSHING mediastinum to opposite side
→ Management: drain the effusion
UNILATERAL WHITE-OUT + TRACHEA DEVIATES TOWARD:
→ MASSIVE ATELECTASIS / LOBAR COLLAPSE
→ Volume is PULLED toward the collapsed side (reduced volume)
→ Management: find the cause of collapse (mucus plug, tumour, foreign body)
→ Bronchoscopy to clear obstruction
The Danger: Draining a "pleural effusion" that is actually massive atelectasis = you introduce a chest drain into collapsed lung tissue = pneumothorax, haemorrhage, iatrogenic disaster.
🧠 MISTAKE 24: Diagnosing "Pulmonary Fibrosis" Without Excluding Connective Tissue Disease
The Error:
HRCT shows bilateral basal interstitial fibrosis. Doctor diagnoses IPF and starts pirfenidone.
Why It Harms:
IPF is a DIAGNOSIS OF EXCLUSION:
Must rule out CTD-associated ILD first:
- Rheumatoid arthritis → RA-ILD (UIP or NSIP pattern)
- Systemic sclerosis → SSc-ILD (NSIP pattern usually)
- Polymyositis/Dermatomyositis → Anti-synthetase syndrome (NSIP + OP)
- Sjogren's → LIP pattern
CTD-ILD management is DIFFERENT from IPF:
→ Immunosuppression (mycophenolate, azathioprine, rituximab) NOT antifibrotics alone
→ Missing CTD = treating with wrong drugs
→ CTD may be treatable and REVERSIBLE in early stages
The Rule: ALL new ILD patients must have:
- ANA, RF, anti-CCP, anti-Scl70, anti-Jo1, anti-synthetase panel, ANCA, myositis panel
- Clinical examination for rashes, joint disease, dry eyes/mouth, Raynaud's
- If CTD antibodies present → rheumatology co-management
SECTION V - EXAMINATION & CONCEPTUAL TRAPS
The tricks that consistently fail students in exams and mislead doctors
📚 MISTAKE 25: Thinking Compliance = Elastance (and Vice Versa)
The Error:
"Emphysema has low compliance because the lung is destroyed."
The Reality:
COMPLIANCE = ΔV / ΔP = how easily the lung stretches
ELASTANCE = 1 / Compliance = how much it resists stretch
Emphysema: DESTROYS elastic fibers → lung is FLOPPY
→ Compliance INCREASES (high) → lung inflates very easily
→ Elastance DECREASES
Fibrosis: ADDS stiff collagen → lung is STIFF
→ Compliance DECREASES (low) → hard to inflate
→ Elastance INCREASES
Students almost universally get this BACKWARDS for emphysema.
📚 MISTAKE 26: Thinking FVC is Only Reduced in Restrictive Disease
The Error:
"FVC is normal, so there's no restriction."
The Reality:
FVC is reduced in BOTH:
RESTRICTIVE: ALL volumes shrink (TLC ↓, FVC ↓, FEV1 ↓) → FEV1/FVC PRESERVED
OBSTRUCTIVE (severe): Air trapping → TLC ↑ but FVC is also REDUCED
because the patient cannot exhale fully (air trapped as RV)
FEV1 falls MORE than FVC → FEV1/FVC falls
Key: FVC alone CANNOT distinguish obstruction from restriction
You NEED FEV1/FVC ratio AND ideally TLC measurement
📚 MISTAKE 27: Assuming Normal PaO2 = No Significant PE
The Error:
"PaO2 is 88 mmHg, so PE is unlikely."
The Reality:
PE causes V/Q mismatch (dead space predominant) + triggers hyperventilation
Hyperventilation LOWERS PaCO2 → RAISES PAO2 (alveolar gas equation)
→ PaO2 can be MAINTAINED in mild-moderate PE by hyperventilation
CORRECT approach: Calculate A-a gradient
Even with "normal" PaO2, the A-a gradient will be WIDENED in PE
(because the patient is hyperventilating to maintain it)
The ABG pattern in classic PE: PaO2 normal/mildly reduced + PaCO2 LOW + respiratory alkalosis + WIDE A-a gradient
📚 MISTAKE 28: Confusing Panacinar and Centriacinar Emphysema
The Common Error:
Students flip A1AT deficiency emphysema (panacinar) with smoking emphysema (centriacinar).
| Type | Distribution | Lobe | Cause |
|---|
| Centriacinar (Centrilobular) | Proximal acinus (respiratory bronchioles) | Upper lobe | Smoking |
| Panacinar (Panlobular) | Entire acinus | Lower lobe | A1AT deficiency |
| Paraseptal | Distal acinus, subpleural | Any; especially upper | Spontaneous PTX in young |
Memory Anchor: "A1AT = All-the-way Through = Panacinar" (affects entire acinus)
📚 MISTAKE 29: Calculating Anion Gap Without Correcting for Albumin
The Error:
"Anion gap is 13 - normal. No HAGMA."
The Danger:
NORMAL ANION GAP assumes normal serum albumin (~40 g/L)
Each 10 g/L decrease in albumin DECREASES the anion gap by 2.5 mEq/L
(Albumin is negatively charged → provides "unmeasured anion" to gap)
In a critically ill patient with albumin of 20 g/L (hypoalbuminaemia):
Corrected AG = Measured AG + 2.5 × (4 - albumin in g/dL)
E.g., Measured AG 13, albumin 2.0 g/dL:
Corrected AG = 13 + 2.5 × (4 - 2.0) = 13 + 5 = 18 → HAGMA PRESENT
Without correction: the underlying HAGMA (e.g., lactic acidosis) is MISSED
📚 MISTAKE 30: Diagnosing Pulmonary Hypertension by Echo Alone (Without RHC)
The Error:
"Echo shows RVSP 55 mmHg, I'll start sildenafil for pulmonary arterial hypertension."
The Danger:
1. RVSP on echo is an ESTIMATE, not a measurement
Poor acoustic windows = grossly inaccurate in 30-40% of patients
2. MOST COMMON PH is GROUP 2 (left heart disease)
Starting sildenafil/bosentan in Group 2 PH:
→ Pulmonary vasodilation without fixing the left heart
→ MORE blood floods into a failing left heart
→ ACUTE PULMONARY OEDEMA
→ Can be fatal
3. GOLD STANDARD: RIGHT HEART CATHETERIZATION
mPAP ≥ 20 mmHg + PAWP ≤ 15 mmHg + PVR ≥ 3 WU = Group 1 PAH
mPAP ≥ 20 mmHg + PAWP > 15 mmHg = Group 2 (left heart origin)
The Rule: NEVER start targeted PAH therapy without RHC confirmation of Group 1 physiology. Echo is for SCREENING only.
SECTION VI - THE "LOOKS LIKE / ISN'T" TRAP TABLE
Classic diagnostic imposters
| Looks Like | Is Actually | Key Distinguisher |
|---|
| COPD exacerbation | Acute heart failure | ECHO + BNP; heart failure has raised JVP + fine crackles bilaterally |
| Asthma attack | Vocal cord dysfunction | Inspiratory stridor + flat inspiratory loop; responds to speech therapy |
| PE | Pleurisy | PE: wide A-a gradient; pleurisy: normal A-a, pleural rub, normal CTPA |
| Pneumothorax | Bulla (emphysema) | CT differentiates; NEVER drain a bulla (can cause massive PTX) |
| Lobar pneumonia | Carcinoma post-obstructive pneumonia | Fails to resolve at 6 weeks on CXR → bronchoscopy |
| IPF | NSIP (CTD-related) | NSIP: temporally uniform, more GGO, less honeycomb, CTD antibodies positive |
| Malignant effusion | Hepatic hydrothorax (cirrhosis) | Serum-ascites albumin gradient; liver function; RUQ USS |
| Type 2 RF in COPD | Opioid/sedative overdose | Both have ↑ PaCO2 + ↓ pH; opioid: miotic pupils + responds to naloxone |
| ARDS | Cardiogenic pulmonary oedema | ARDS: PAWP < 18 mmHg; oedema: PAWP > 18, responds to diuretics |
| Sarcoidosis | Lymphoma (mediastinal) | Lymph node biopsy; lymphoma: Reed-Sternberg cells; sarcoid: non-caseating granuloma |
| Lambert-Eaton | Myasthenia Gravis | LEMS improves with repetition; MG worsens; LEMS has autonomic features |
SECTION VII - THE "NEVER DO" RULES IN PULMONARY MEDICINE
☠️ NEVER wait for a CXR before treating tension pneumothorax
☠️ NEVER give high-flow O2 to a known CO2-retaining COPD patient
☠️ NEVER interpret a silent chest in acute asthma as improvement
☠️ NEVER prescribe a beta-blocker (including eye drops) in asthma
☠️ NEVER prescribe LABA without ICS in asthma
☠️ NEVER start steroids for "sarcoidosis" without excluding TB
☠️ NEVER drain a pneumothorax you haven't confirmed isn't a bulla
☠️ NEVER use normal (12 mL/kg) tidal volumes in ARDS
☠️ NEVER give ASV to a patient with heart failure EF < 45%
☠️ NEVER trust a normal CXR to exclude PE in a breathless tachycardic patient
☠️ NEVER start targeted PAH therapy without confirming Group 1 with RHC
☠️ NEVER diagnose IPF without excluding connective tissue disease
☠️ NEVER give thrombolytics in PE without considering haemostasis (recent surgery, stroke)
☠️ NEVER treat auto-PEEP-induced hypotension with fluids without first trying disconnection
☠️ NEVER calculate anion gap without correcting for hypoalbuminaemia in sick patients
SECTION VIII - RAPID CLINICAL SAFETY RULES
The 10 clinical safety rules you should recite before every respiratory emergency:
1. BREATHLESS + TACHYCARDIA + NORMAL CXR = PE until proven otherwise
2. ASTHMA + SILENT CHEST = near-fatal, not improving
3. COPD + HIGH O2 = CO2 narcosis risk → 88-92% target
4. TENSION PTX = clinical diagnosis = needle first, image never
5. ARDS = 6 mL/kg IBW + PEEP ≥5 + P/F <150 → PRONE
6. PE + HAEMODYNAMIC INSTABILITY = thrombolyse (after confirming or if rapidly dying)
7. GRANULOMA + "SARCOIDOSIS" = exclude TB before steroids
8. SCLC + PROXIMAL WEAKNESS = LEMS not MG (check VGCC antibodies)
9. PLEURAL WHITE-OUT = check trachea first (away = effusion; toward = collapse)
10. RAISED ANION GAP = correct for albumin; check delta-delta ratio
This compendium captures the errors that appear most frequently in clinical practice, malpractice cases, USMLE exams, and viva traps. The student who knows what NOT to do is already safer than most - because most harm comes not from ignorance of the exotic, but from the misapplication of the common.
SUMMARY BY CATEGORY
| Category | Errors Covered |
|---|
| Instantly fatal | Tension PTX delay, COPD + high O2, silent chest, rising PaCO2 in asthma, PE thrombolysis delay |
| Drug errors | Beta-blockers in asthma (including eye drops), LABA monotherapy, theophylline interactions, ASV in CHF |
| Diagnostic errors | Normal CXR + PE, LEMS vs MG, H-type TEF, pre-BD spirometry, diuretics + Light's, TB vs sarcoid |
| Reasoning errors | ARDS tidal volume, auto-PEEP, proning threshold, FVC interpretation, A-a gradient in hypoventilation |
| Exam traps | Compliance vs elastance, FVC in obstruction, PaO2 in PE, panacinar vs centriacinar, albumin-corrected AG, RHC before PAH drugs |
| Imposter diagnoses | 10 "looks like / is actually" pairs covering the full course spectrum |